A review of esophageal chest pain

Enrique Coss-Adame, Satish S.C. Rao

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Noncardiac chest pain is a term that encompasses all causes of chest pain after a cardiac source has been excluded. This article focuses on esophageal sources for chest pain. Esophageal chest pain (ECP) is common, affects quality of life, and carries a substantial health care burden. The lack of a systematic approach toward the diagnosis and treatment of ECP has led to significant disability and increased health care costs for this condition. Identifying the underlying cause(s) or mechanism(s) for chest pain is key for its successful management. Common etiologies include gastroesophageal reflux disease, esophageal hypersensitivity, dysmotility, and psychological conditions, including panic disorder and anxiety. However, the pathophysiology of this condition is not yet fully understood. Randomized controlled trials have shown that proton pump inhibitor therapy (either omeprazole, lansoprazole, or rabeprazole) can be effective. Evidence for the use of antidepressants and the adenosine receptor antagonist theophylline is fair. Psychological treatments, notably cognitive behavioral therapy, may be useful in select patients. Surgery is not recommended. There remains a large unmet need for identifying the phenotype and prevalence of pathophysiologic mechanisms of ECP as well as for well-designed multicenter clinical trials of current and novel therapies.

Original languageEnglish (US)
Pages (from-to)759-766
Number of pages8
JournalGastroenterology and Hepatology
Volume11
Issue number11
StatePublished - Nov 2015

Fingerprint

Chest Pain
Rabeprazole
Esophageal Motility Disorders
Psychology
Purinergic P1 Receptor Antagonists
Lansoprazole
Omeprazole
Proton Pump Inhibitors
Panic Disorder
Cognitive Therapy
Therapeutics
Theophylline
Gastroesophageal Reflux
Health Care Costs
Antidepressive Agents
Multicenter Studies
Hypersensitivity
Anxiety
Randomized Controlled Trials
Quality of Life

Keywords

  • Esophageal chest pain
  • Noncardiac chest pain
  • Pathophysiology
  • Treatment

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

A review of esophageal chest pain. / Coss-Adame, Enrique; Rao, Satish S.C.

In: Gastroenterology and Hepatology, Vol. 11, No. 11, 11.2015, p. 759-766.

Research output: Contribution to journalReview article

Coss-Adame, E & Rao, SSC 2015, 'A review of esophageal chest pain', Gastroenterology and Hepatology, vol. 11, no. 11, pp. 759-766.
Coss-Adame, Enrique ; Rao, Satish S.C. / A review of esophageal chest pain. In: Gastroenterology and Hepatology. 2015 ; Vol. 11, No. 11. pp. 759-766.
@article{42113a68d75f438fb0cc4eb8ec3fd171,
title = "A review of esophageal chest pain",
abstract = "Noncardiac chest pain is a term that encompasses all causes of chest pain after a cardiac source has been excluded. This article focuses on esophageal sources for chest pain. Esophageal chest pain (ECP) is common, affects quality of life, and carries a substantial health care burden. The lack of a systematic approach toward the diagnosis and treatment of ECP has led to significant disability and increased health care costs for this condition. Identifying the underlying cause(s) or mechanism(s) for chest pain is key for its successful management. Common etiologies include gastroesophageal reflux disease, esophageal hypersensitivity, dysmotility, and psychological conditions, including panic disorder and anxiety. However, the pathophysiology of this condition is not yet fully understood. Randomized controlled trials have shown that proton pump inhibitor therapy (either omeprazole, lansoprazole, or rabeprazole) can be effective. Evidence for the use of antidepressants and the adenosine receptor antagonist theophylline is fair. Psychological treatments, notably cognitive behavioral therapy, may be useful in select patients. Surgery is not recommended. There remains a large unmet need for identifying the phenotype and prevalence of pathophysiologic mechanisms of ECP as well as for well-designed multicenter clinical trials of current and novel therapies.",
keywords = "Esophageal chest pain, Noncardiac chest pain, Pathophysiology, Treatment",
author = "Enrique Coss-Adame and Rao, {Satish S.C.}",
year = "2015",
month = "11",
language = "English (US)",
volume = "11",
pages = "759--766",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "11",

}

TY - JOUR

T1 - A review of esophageal chest pain

AU - Coss-Adame, Enrique

AU - Rao, Satish S.C.

PY - 2015/11

Y1 - 2015/11

N2 - Noncardiac chest pain is a term that encompasses all causes of chest pain after a cardiac source has been excluded. This article focuses on esophageal sources for chest pain. Esophageal chest pain (ECP) is common, affects quality of life, and carries a substantial health care burden. The lack of a systematic approach toward the diagnosis and treatment of ECP has led to significant disability and increased health care costs for this condition. Identifying the underlying cause(s) or mechanism(s) for chest pain is key for its successful management. Common etiologies include gastroesophageal reflux disease, esophageal hypersensitivity, dysmotility, and psychological conditions, including panic disorder and anxiety. However, the pathophysiology of this condition is not yet fully understood. Randomized controlled trials have shown that proton pump inhibitor therapy (either omeprazole, lansoprazole, or rabeprazole) can be effective. Evidence for the use of antidepressants and the adenosine receptor antagonist theophylline is fair. Psychological treatments, notably cognitive behavioral therapy, may be useful in select patients. Surgery is not recommended. There remains a large unmet need for identifying the phenotype and prevalence of pathophysiologic mechanisms of ECP as well as for well-designed multicenter clinical trials of current and novel therapies.

AB - Noncardiac chest pain is a term that encompasses all causes of chest pain after a cardiac source has been excluded. This article focuses on esophageal sources for chest pain. Esophageal chest pain (ECP) is common, affects quality of life, and carries a substantial health care burden. The lack of a systematic approach toward the diagnosis and treatment of ECP has led to significant disability and increased health care costs for this condition. Identifying the underlying cause(s) or mechanism(s) for chest pain is key for its successful management. Common etiologies include gastroesophageal reflux disease, esophageal hypersensitivity, dysmotility, and psychological conditions, including panic disorder and anxiety. However, the pathophysiology of this condition is not yet fully understood. Randomized controlled trials have shown that proton pump inhibitor therapy (either omeprazole, lansoprazole, or rabeprazole) can be effective. Evidence for the use of antidepressants and the adenosine receptor antagonist theophylline is fair. Psychological treatments, notably cognitive behavioral therapy, may be useful in select patients. Surgery is not recommended. There remains a large unmet need for identifying the phenotype and prevalence of pathophysiologic mechanisms of ECP as well as for well-designed multicenter clinical trials of current and novel therapies.

KW - Esophageal chest pain

KW - Noncardiac chest pain

KW - Pathophysiology

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84947736974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947736974&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84947736974

VL - 11

SP - 759

EP - 766

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 11

ER -